Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

F-Star Therapeutics Inc (FSTX)

F-Star Therapeutics Inc (FSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

F-Star Therapeutics Inc Eddeva B920 Babraham Research Campus CAMBRIDGE X0 CB22 3AT GBR

www.f-star.com P: 44-12-2349-7400

Description:

F-star Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. F-star Therapeutics Inc., formerly known as Spring Bank Pharmaceuticals Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 156,512
Enterprise Value, $K 87,572
Shares Outstanding, K 21,982
Annual Sales, $ 21,170 K
Annual Net Income, $ -31,280 K
Last Quarter Sales, $ 1,130 K
Last Quarter Net Income, $ -18,410 K
60-Month Beta 0.85
% of Insider Shareholders 3.20%
% of Institutional Shareholders 31.50%
Float, K 21,279
% Float 96.80%
Short Volume Ratio 0.55

Growth:

1-Year Return 145.94%
3-Year Return 85.42%
5-Year Return -88.27%
5-Year Revenue Growth 5,948.57%
5-Year Earnings Growth 82.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.84 on 11/10/22
Latest Earnings Date 03/13/23
Earnings Per Share ttm -1.82
EPS Growth vs. Prev Qtr 4.55%
EPS Growth vs. Prev Year -61.54%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/23/20

FSTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -57.08%
Return-on-Assets % -42.41%
Profit Margin % -147.76%
Debt/Equity 0.15
Price/Sales 7.16
Price/Cash Flow N/A
Price/Book 2.75
Book Value/Share 2.59
Interest Coverage -36.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar